Cargando…
1410. Novel Framework to Compare the Effectiveness of Tazobactam, Relebactam and Avibactam Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
BACKGROUND: Resistance mediated by extended-spectrum β-lactamases (ESBLs) presents a serious challenge in the treatment of Gram-negative pathogens. ESBLs confer resistance to most β-lactams which may be reversed with the addition of an active β-lactamase inhibitor (such as tazobactam, relebactam and...
Autores principales: | Abodakpi, Henrietta, Chang, Kai-Tai, Byerly, Caitlan, Tam, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254093/ http://dx.doi.org/10.1093/ofid/ofy210.1241 |
Ejemplares similares
-
1409. Evaluation of Alternative Piperacillin–tazobactam Dosing Strategies Against ESBL-Producing Enterobacteriaceae Using a Hollowfiber Infection Model
por: Abodakpi, Henrietta, et al.
Publicado: (2018) -
Activity of Ceftolozane/tazobactam (C/T) and Ceftazidime/avibactam (CZA) against Extended-spectrum Β-lactamase (ESBL)-producing Enterobacteriaceae and Multidrug-resistant (MDR) Pseudomonas aeruginosa Isolates
por: Hirsch, Elizabeth B, et al.
Publicado: (2017) -
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
por: Ng, Tat Ming, et al.
Publicado: (2016) -
Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018) -
Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Fresh Produce
por: Pintor-Cora, Alberto, et al.
Publicado: (2021)